NCT06176716View on ClinicalTrials.gov

Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 6, 2023

Primary Completion Date

March 30, 2024

Study Completion Date

April 30, 2024

Conditions
Hepatic Insufficiency
Interventions
DRUG

ET-26

The dose is 0.8 mg/kg, single dose, Infusion time was 60s ± 5s.

Trial Locations (1)

130021

RECRUITING

First Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Ahon Pharmaceutical Co., Ltd.

OTHER